OASYS NOW: 10 Key Things You Must Know

Overview

OASYS NOW is an innovative health-tech startup headquartered in Delft, Netherlands, known for its pioneering use of AI to streamline clinical trial recruitment. Founded in 2018 by Nima Salami and Sara Okhuijsen, the company focuses on harnessing AI technology to improve the pace and precision of patient recruitment for clinical trials. This effort is particularly significant in the realm of personalized medicine, as it seeks to make state-of-the-art healthcare accessible to patients around the globe. The company recently garnered significant attention after winning the prestigious Slush 100 competition, receiving a €1 million equity investment to further bolster its mission.

1. Founding Mission

OASYS NOW was established with the core mission of enhancing healthcare accessibility through personalized medicine. Co-founder Nima Salami, inspired by personal experiences, particularly with his mother’s chronic health condition, sought to bridge the gap between patients and researchers. This experience highlighted the critical need for seamless access to health data and trial opportunities, inspiring OASYS NOW’s commitment to empowering patients through technology.

2. Innovative AI Platform

The cornerstone of OASYS NOW is its AI-driven platform designed to revolutionize patient recruitment for clinical trials. The platform automates the process of finding eligible patients by analyzing electronic health records (EHR). This approach not only expedites the recruitment process but also enhances the precision with which patients are matched to appropriate trials, significantly reducing the traditional trial recruitment bottlenecks.

3. Clinical Trial Disruption

By improving how patients are recruited for clinical trials, OASYS NOW addresses a critical challenge in drug development. Traditional patient recruitment is often time-consuming and inefficient, delaying potentially lifesaving drug research. OASYS NOW’s technology accelerates patient identification, facilitating faster and more effective trial enrollment—a crucial breakthrough for patient-centric healthcare advancements.

4. Privacy and Data Security

Committed to data privacy, OASYS NOW implements stringent measures to ensure patient data protection. The platform is compliant with GDPR standards, and all data is encrypted and anonymized to uphold patient confidentiality. This privacy-first approach positions the startup as a trusted partner in the healthcare sector, particularly in sensitive data management.

5. Slush 100 Competition Victory

In 2024, OASYS NOW captured industry attention by winning the Slush 100 startup competition, a prestigious event that recognizes promising new tech companies. The victory came with a €1 million investment from venture funds General Catalyst and Cherry Ventures, which will aid the expansion of their team and technology infrastructure, further advancing their revolutionary healthcare initiatives.

6. The ELaiGIBLE Platform

Central to OASYS NOW’s offering is the ELaiGIBLE Platform, which simplifies the clinical trial matching process. This software integrates directly with clinical trial databases, allowing healthcare professionals to quickly identify suitable trial participants, thus reducing the time needed to match patients from months to mere minutes. This efficiency helps meet recruitment targets faster, benefiting both patients and research institutions.

7. GRIP App

Another key product, the GRIP app, empowers individuals by giving them control over their health data. Users can access personalized health insights and trial options tailored to their unique health profiles. This level of engagement not only empowers patients but also enables them quicker access to necessary treatments, bridging the gap between needing care and receiving it.

8. Partnership with Progress Clinical Research

OASYS NOW recently partnered with Progress Clinical Research to further enhance patient recruitment capabilities. This collaboration aims to leverage OASYS NOW’s AI technologies to streamline processes and reduce the barriers that impede clinical trials, enhancing the delivery of life-saving treatments and accelerating medical advancements in diseases with high unmet medical needs.

9. Expansion Focus

With its recent funding, OASYS NOW plans to expand its operations, focusing on increasing its workforce, particularly in engineering and development. The expansion will enable the company to enhance its AI platform's capabilities, thereby broadening its impact in the healthcare sector, particularly in Europe.

10. Future Prospects

OASYS NOW is poised for significant growth, with ambitions to expand its AI application beyond Europe, targeting global health challenges. The company’s mission to democratize healthcare through precision medicine positions it uniquely to navigate and potentially reshape the future of clinical research and patient care, making advanced healthcare accessible to a broader audience.

Conclusion

OASYS NOW is at the forefront of a healthcare revolution, leveraging AI to optimize and expedite clinical trials. Its innovative approaches to patient recruitment and commitment to data privacy give it strong potential to impact the global health landscape significantly. As it expands, OASYS NOW stands as a beacon of innovation, aiming to transform how clinical data is utilized and how patients access cutting-edge treatments. This focus not only promises to enhance treatment options but also catalyzes progress towards a more inclusive and efficient healthcare system.